Modulation of blood pressure by central melanocortinergic pathways
- PMID: 19092146
- DOI: 10.1056/NEJMoa0803085
Modulation of blood pressure by central melanocortinergic pathways
Abstract
Background: Weight gain and weight loss are associated with changes in blood pressure through unknown mechanisms. Central melanocortinergic signaling is implicated in the control of energy balance and blood pressure in rodents, but there is no information regarding such an association with blood pressure in humans.
Methods: We assessed blood pressure, heart rate, and urinary catecholamines in overweight or obese subjects with a loss-of-function mutation in MC4R, the gene encoding the melanocortin 4 receptor, and in equally overweight control subjects. We also examined the effects of an MC4R agonist administered for 7 days in 28 overweight or obese volunteers.
Results: The prevalence of hypertension was markedly lower in the MC4R-deficient subjects than in the control subjects (24% vs. 53%, P=0.009). After the exclusion of subjects taking antihypertensive medications, blood-pressure levels were significantly lower in MC4R-deficient subjects than in control subjects, with mean (+/-SE) systolic blood pressures of 123+/-14 mm Hg and 131+/-12 mm Hg, respectively (P=0.02), and mean diastolic blood pressures of 73+/-10 mm Hg and 79+/-7 mm Hg, respectively (P=0.03). As compared with control subjects, MC4R-deficient subjects had a lower increase in heart rate on waking (P=0.007), a lower heart rate during euglycemic hyperinsulinemia (P<0.001), and lower 24-hour urinary norepinephrine excretion (P=0.04). The maximum tolerated daily dose of 1.0 mg of the MC4R agonist led to significant increases of 9.3+/-1.9 mm Hg in systolic blood pressure and of 6.6+/-1.1 mm Hg in diastolic blood pressure (P<0.001 for both comparisons) at 24 hours, as compared with placebo. Differences in blood pressure were not explained by changes in insulin levels; there were no significant adverse events.
Conclusions: Results of our genetic and pharmacologic studies implicate melanocortinergic signaling in the control of human blood pressure through an insulin-independent mechanism.
2009 Massachusetts Medical Society
Similar articles
-
Melanocortin signalling and the regulation of blood pressure in human obesity.J Neuroendocrinol. 2011 Feb;23(2):186-93. doi: 10.1111/j.1365-2826.2010.02088.x. J Neuroendocrinol. 2011. PMID: 21062377 Review.
-
Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia.Hypertension. 2005 Aug;46(2):326-32. doi: 10.1161/01.HYP.0000175474.99326.bf. Epub 2005 Jul 18. Hypertension. 2005. PMID: 16027245
-
Sympathetic function in human carriers of melanocortin-4 receptor gene mutations.J Clin Endocrinol Metab. 2010 Apr;95(4):1998-2002. doi: 10.1210/jc.2009-2297. Epub 2010 Feb 10. J Clin Endocrinol Metab. 2010. PMID: 20147580
-
Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R803-12. doi: 10.1152/ajpregu.00187.2009. Epub 2009 Jul 15. Am J Physiol Regul Integr Comp Physiol. 2009. PMID: 19605765 Free PMC article.
-
Role of the brain melanocortins in blood pressure regulation.Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2508-2514. doi: 10.1016/j.bbadis.2017.03.003. Epub 2017 Mar 6. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28274841 Free PMC article. Review.
Cited by
-
Delineation of the central melanocortin circuitry controlling the kidneys by a virally mediated transsynaptic tracing study in transgenic mouse model.Oncotarget. 2016 Oct 25;7(43):69256-69266. doi: 10.18632/oncotarget.11956. Oncotarget. 2016. PMID: 27626491 Free PMC article.
-
Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension.Cardiovasc Diabetol. 2013 Jul 12;12:103. doi: 10.1186/1475-2840-12-103. Cardiovasc Diabetol. 2013. PMID: 23849767 Free PMC article.
-
Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats.J Hypertens. 2015 Jun;33(6):1201-6. doi: 10.1097/HJH.0000000000000530. J Hypertens. 2015. PMID: 25668357 Free PMC article.
-
The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.Antioxid Redox Signal. 2014 Jan 1;20(1):102-20. doi: 10.1089/ars.2013.5258. Epub 2013 Apr 19. Antioxid Redox Signal. 2014. PMID: 23472597 Free PMC article. Review.
-
Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons.Cell. 2013 Jan 31;152(3):612-9. doi: 10.1016/j.cell.2012.12.022. Cell. 2013. PMID: 23374353 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials